Adaptive Biotechnologies Corp. (ADPT)
16.28
-0.37
(-2.22%)
USD |
NASDAQ |
Dec 30, 11:13
Adaptive Biotechnologies EPS Diluted (Quarterly): 0.0585 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 13.62 |
| Zymeworks, Inc. | -0.2587 |
| Cue Biopharma, Inc. | -0.0738 |
| Recursion Pharmaceuticals, Inc. | -0.363 |
| Arcellx, Inc. | -0.9858 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 9.545M |
| Revenue (Quarterly) | 93.97M |
| Total Expenses (Quarterly) | 84.43M |
| Enterprise Value | 2.543B |
| Gross Profit Margin (Quarterly) | 77.30% |
| Profit Margin (Quarterly) | 10.16% |
| Earnings Yield | -3.31% |
| Normalized Earnings Yield | -3.303 |